Phio Pharmaceuticals Appoints Dr. John Barrett as Chief Development Officer

MARLBOROUGH, Mass., April 10, 2019 -- (Healthcare Sales & Marketing Network) -- Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi... Biopharmaceuticals, Oncology, Personnel Phio Pharmaceuticals, immuno-oncology, immunotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news